Next Article in Journal
Neutrophil Extracellular Traps in Skin Diseases
Next Article in Special Issue
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
Previous Article in Journal
Rewarding Social Interaction in Rats Increases CaMKII in the Nucleus Accumbens
Previous Article in Special Issue
Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1
 
 
Communication
Peer-Review Record

Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of Recurrence

Biomedicines 2021, 9(12), 1887; https://doi.org/10.3390/biomedicines9121887
by Stéphanie Blockhuys 1,*, Camilla Hildesjö 2, Hans Olsson 2, Linda Vahdat 3 and Pernilla Wittung-Stafshede 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2021, 9(12), 1887; https://doi.org/10.3390/biomedicines9121887
Submission received: 15 July 2021 / Revised: 3 August 2021 / Accepted: 13 August 2021 / Published: 12 December 2021
(This article belongs to the Special Issue Breast Cancer: Molecular Basis and Translational Research)

Round 1

Reviewer 1 Report

Congratulations for the paper.

The article is suitable for publication in the present form.

Author Response

Thank you very much for accepting our manuscript.

Reviewer 2 Report

1. Line 37, typo for heat

2. I Would request to arrange 3AC as 3AB and 3BD as 3CD for easy understanding.

3. Did the authors see some cases having both cytoplasimic and nuclear expression? It is evident in Fig.1A. The IHC image quality should be improved. 

4. A better resolution Fig 4 should be added. Some months are not readable. p value is missing in Fig. 4B

5. More discussion on the expression pattern of ATOX1 and functional role in various cancer will be informative and useful for the readers.

6. A table with patients demographics will be helpful.

Author Response

Please find my response to your comments in the file attached. 

Thank you for your comments. 

 

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

The authors have addressed all concerns.

Back to TopTop